Hyperion Therapeutics Secures $17,471,998 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5fd06335-c0f2-4d67-b802-a0812029b04b&Preview=1
Date
4/18/2011
Company Name
Hyperion Therapeutics
Mailing Address
601 Gateway Blvd South San Francisco, CA 94080
Company Description
Hyperion Therapeutics, Inc. is a privately held specialty biopharmaceutical company dedicated to improving patients’ lives through the development and commercialization of therapies that address critical unmet needs and underserved patient populations. The Company’s initial efforts are focused in the areas of gastroenterology and hepatology.
Website
http://www.hyperiontx.com
Transaction Type
Debt, Venture Equity
Transaction Amount
$17,471,998
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed